Positive outcome no more likely in industry-funded trials
(HealthDay) -- Industry-sponsored clinical trials of rheumatoid arthritis drugs are no more likely to report positive outcomes than trials funded by other means, and in many cases use better methodology, according to research ...
Jul 5, 2012
1
0